Optimal timing of routine vaccination in HIV-infected persons.
Vaccine recommendations for those with HIV require continual updating as additional research becomes available. Timing of vaccinations among HIV-infected individuals is a key area of uncertainty. This is particularly true for those who may soon initiate highly active antiretroviral therapy (HAART) because immune reconstitution due to HAART often improves responses to vaccines. However, risks of delaying vaccination include that the patient may be exposed to the pathogen or lost to follow-up before vaccination. We review recent studies on the timing of routine vaccination of HIV-infected individuals.
Crane
Heidi M
HM
Center for AIDS and STD Research, University of Washington, Harborview Medical Center, Box 359931, 325 9th Avenue, Seattle, WA 98104, USA. hcrane@u.washington.edu
Dhanireddy
Shireesha
S
Kim
H Nina
HN
Ramers
Christian
C
Dellit
Timothy H
TH
Kitahata
Mari M
MM
Harrington
Robert D
RD
D000293:Adolescent; D000328:Adult; D001428:Bacterial Vaccines / Q000008:administration & dosage*; D015658:HIV Infections / Q000276:immunology*; D006801:Humans; D007115:Immunization Schedule; D014611:Vaccination; D014765:Viral Vaccines / Q000008:administration & dosage*; D055815:Young Adult
D001428:Bacterial Vaccines; D014765:Viral Vaccines